Melphalan
Showing 26 - 50 of 1,022
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- Fludarabine
- +2 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023
Multiple Myeloma Trial in Hackensack (Fludarabine monophosphate, melphalan, Bortezomib)
Completed
- Multiple Myeloma
- Fludarabine monophosphate, melphalan, Bortezomib
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Apr 29, 2022
Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood
Recruiting
- Hematopoietic Malignancy
- +2 more
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Nov 6, 2023
Melanoma, Ocular Trial in Tampa, Durham (Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS))
Available
- Melanoma, Ocular
- Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS)
-
Tampa, Florida
- +1 more
Mar 23, 2022
Leukemia, MDS Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- fludarabine phosphate
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
Multiple Myeloma Trial in Torino (Cyclophosphamide, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Cyclophosphamide
- +3 more
-
Torino, ItalyDivision of Hematology, Molinette Hospital
Apr 6, 2022
Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Fludarabine, busulfan and melphalan
- Fludarabine and Busulfan
-
Fuzhou, Fujian, China
- +8 more
Aug 14, 2023
Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)
Active, not recruiting
- Primary Systemic Amyloidosis
- Light Chain Deposition Disease
- bortezomib
- +6 more
-
Denver, Colorado
- +6 more
Aug 24, 2022
Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)
Recruiting
- Leukemia
- Melphalan
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022
Multiple Myeloma Trial in Torino (velcade subcutaneous melphalan prednisone, velcade cyclophosphamide prednisone, velcade
Active, not recruiting
- Multiple Myeloma
- velcade subcutaneous melphalan prednisone
- +2 more
-
Torino, ItalyA.O.U. Città della Salute e della Scienza di Torino - SC Ematolo
Mar 24, 2022
Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)
Active, not recruiting
- Multiple Myeloma
- Amyloidosis
- Melphalan
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)
Active, not recruiting
- Plasma Cell Leukemia
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Unilateral Retinoblastoma Trial (Biospecimen Collection,
Not yet recruiting
- Bilateral Retinoblastoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Aug 17, 2022
Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment Trial in Chicago (radiation, drug, procedure)
Completed
- Multiple Myeloma, Relapsed
- Multiple Myeloma, Refractory to Standard Treatment
- Total Marrow Irradiation
- +3 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Nov 20, 2021
Oral Mucositis in Patient's Undergoing Melphalan Conditioning
Withdrawn
- Mucositis
- +3 more
- Melphalan kinetic study
- +2 more
-
Indianapolis, Indiana
- +1 more
Jan 6, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Multiple Myeloma Trial in Torino (Melphalan, Prednisone, Lenalidomide, Cyclophosphamide, Prednisone, Lenalidomide, Lenalidomide,
Active, not recruiting
- Multiple Myeloma
- Melphalan, Prednisone, Lenalidomide
- +2 more
-
Torino, TO, ItalyDivision Of Hematology, A.O.U. Città della Salute e della Scienz
Mar 24, 2022
Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)
Recruiting
- Multiple Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Atlanta, Georgia
- +1 more
Feb 25, 2022
Hematopoietic Stem Cell Transplantation Trial in Cincinnati (Melphalan)
Completed
- Hematopoietic Stem Cell Transplantation
- Melphalan
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 24, 2021
Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)
Recruiting
- Plasma Cell Myeloma
- Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 27, 2022
Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)
Completed
- Multiple Myeloma
- Melphalan
- Bendamustine
-
Berne, SwitzerlandDepartment for Medical Oncology University Hospital/Inselspital
Jul 29, 2021
Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancies
- Busulfan 3.2 mg/kg/day
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 14, 2022
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022